Skip to content
You can now search across every topic, entity and event.What's new
Pandemics and Biosecurity
12MAY

US Ebola entry ban nears expiry

3 min read
16:29UTC

The 30-day US entry ban on DRC, Uganda and South Sudan nationals, widened to green-card holders on 5 June, expires around 17 June with no announced lift. Africa CDC calls it of 'little, if any, benefit'.

ScienceDeveloping
Key takeaway

The US Ebola entry ban reaches its 17 June expiry unresolved, while Washington funds the response it restricts.

A 30-day US entry ban on nationals of the Democratic Republic of the Congo, Uganda and South Sudan, expanded on 5 June to include green-card holders , expires around 17 June with no announced extension, modification or lift as of publication. The ban is administered by the US Department of Health and Human Services, the federal department overseeing public health. The Africa CDC Emergency Consultative Group, the continental agency's scientific advisory body on outbreaks, calls the restriction of "little, if any, benefit" 1.

The scientific case against entry bans is settled and has been since the 2014 West Africa epidemic. They delay rather than prevent importation, they displace travel through unscreened overland routes, and they deter the surveillance cooperation that lets responders see a virus coming. The original order, issued 18 May , rests on the same reasoning that the evidence rejects.

The same administration funding hundreds of millions of dollars of the response is restricting movement through the borders that response depends on partners keeping open. As of publication the border restriction stands as established fact; its fate at expiry is genuinely open, neither a reported lift nor a confirmed extension.

Deep Analysis

In plain English

The United States imposed a ban on 18 May preventing nationals of DRC, Uganda and South Sudan from entering the country. On 5 June it was expanded to include green-card holders, people who live legally in the US, from those same countries. The ban was due to expire around 17 June, but as of publication, no announcement had been made about whether it would be lifted, renewed or changed. Public health experts, including the WHO and Africa CDC, are against entry bans because they do not actually prevent the virus from reaching other countries. What they do is push travellers to take indirect routes through countries with less screening, and they make it harder for healthcare workers and scientists to travel to and from the outbreak zone. The US is simultaneously spending $270 million to fight the outbreak it is restricting people from fleeing.

Deep Analysis
Root Causes

Two structural forces sustain entry bans despite their epidemiological ineffectiveness. Domestic political risk calculus: elected governments face asymmetric accountability, if a banned national imports the virus, the absence of the ban becomes the explanatory variable in public and legislative discourse, regardless of screening capacity at borders. The cost of being seen to have permitted importation is politically higher than the cost of maintaining a restriction that impedes response.

A legal architecture gap reinforces the political dynamic. The IHR Temporary Recommendations issued 22 May explicitly advise against travel and trade restrictions, but the IHR has no enforcement mechanism. States that impose restrictions contrary to Temporary Recommendations face no formal consequence beyond WHO censure; the US's $270 million bilateral funding commitment demonstrates that the DRC and Ugandan governments are not in a position to impose a symmetrical diplomatic penalty.

What could happen next?
  • Consequence

    If the ban is extended past 17 June, it risks reducing the flow of outbreak-trained DRC and Ugandan epidemiologists to international conferences and WHO technical meetings, compounding the surveillance cooperation gap that the WHO Pandemic Agreement's deadlocked PABS annex (ID:4053) already creates.

    Short term · Reported
  • Precedent

    A 30-day ban that runs through PHEIC declaration and generates no documented importation-prevention evidence, while coexisting with $270 million in bilateral response funding, establishes a domestic-politics-over-epidemiology precedent that other governments may cite in future outbreak declarations.

    Long term · Reported
  • Risk

    The ban's displacement effect, pushing DRC and Ugandan nationals through unscreened third-country routes, may generate importation events in countries with less detection capacity than the US, creating secondary spread that the ban was nominally designed to prevent.

    Short term · Reported
First Reported In

Update #7 · Bundibugyo's fork stays open

Africa CDC· 16 Jun 2026
Read original
Different Perspectives
Germany (evacuation recipient)
Germany (evacuation recipient)
Germany received the Bundibugyo outbreak's third international medical evacuation on 13 July, a US humanitarian worker infected in Bunia on 10 July. The evacuation, following a French doctor's 24 June departure and May's first US case, tests whether isolation and biocontainment protocols scale beyond DR Congo's own borders.
Pennsylvania Department of Public Health
Pennsylvania Department of Public Health
PDPH retested and retracted a false-positive measles wastewater signal on 6 July, then confirmed and publicised a real airport exposure from 4 July, with commissioner Palak Raval-Nelson stressing there is no broad threat to the general public. The national count, 2,231 cases across 42 states by 9 July, is on pace to beat 2025's 2,289-case record before September.
World Health Organization
World Health Organization
WHO published its first dedicated Blueprint on fungal disease and antifungal resistance on 1 July, estimating more than 300 million people suffer serious fungal disease annually. The Blueprint names the gap in WHO's own AMR strategy rather than waiting for an external audit to force the admission.
Africa CDC
Africa CDC
Africa CDC issued a formal 11 July appeal for responder protection, training and psychosocial support after health-worker infections tripled from 34 to 112 in a month. The appeal repeats June's unmet call for a rapid Bundibugyo diagnostic test, showing the ask has shifted from tools to basic safety and pay.
Front-line health workers, Ituri Province
Front-line health workers, Ituri Province
Health workers in Ituri Province walked off the job or threatened to strike over unpaid hazard pay and delayed salaries, even as responder infections tripled to 112 with 35 dead. Their absence narrows the isolation workforce the CDC's model says must reach 70% coverage to avoid a 20,000-case worst case.
ECDC
ECDC
ECDC co-published the isolation and contact-tracing figures behind WHO's DON612, tracking Ituri's isolation rate rising from 35 to 44 percent while still rating EU/EEA import risk as very low. Brussels backs the WHO line against travel restrictions, the position France's own contact-tracing response, not the US entry ban, actually validated.